310 related articles for article (PubMed ID: 10763851)
1. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
3. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
[TBL] [Abstract][Full Text] [Related]
4. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
Vyas S; Ahmadi B; Hammond JR
Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
[TBL] [Abstract][Full Text] [Related]
5. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
Ward JL; Sherali A; Mo ZP; Tse CM
J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.
Kiss A; Farah K; Kim J; Garriock RJ; Drysdale TA; Hammond JR
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):363-72. PubMed ID: 11085929
[TBL] [Abstract][Full Text] [Related]
7. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
[TBL] [Abstract][Full Text] [Related]
10. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
Crawford CR; Patel DH; Naeve C; Belt JA
J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.
Archer RG; Pitelka V; Hammond JR
Br J Pharmacol; 2004 Sep; 143(1):202-14. PubMed ID: 15289294
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.
Burke T; Lee S; Ferguson PJ; Hammond JR
J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells.
Ward JL; Tse CM
Biochim Biophys Acta; 1999 Jun; 1419(1):15-22. PubMed ID: 10366666
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Hammond JR; Stolk M; Archer RG; McConnell K
Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the novel adenosine uptake inhibitor 3-[1-(6,7-diethoxy-2-morpholinoquinazolin-4-yl)piperidin-4-yl]-1,6-dimethyl-2,4(1H,3H)-quinazolinedione hydrochloride (KF24345) with the es and ei subtypes of equilibrative nucleoside transporters.
Hammond JR; Archer RG
J Pharmacol Exp Ther; 2004 Mar; 308(3):1083-93. PubMed ID: 14634039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
